compound introduction
Y2603618是一种选择性Chk1抑制剂，具有潜在的抗肿瘤活性。Phase 2。A selective Chk1 inhibitor. LY2603618 is a selective Chk1 inhibitor with potential anti-tumor activity. Phase 2. A selective Chk1 inhibitor.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
LY2603618
CAS number：911222-45-2 molecular formula：C18H22BrN5O3
overview
Specs
| Chinese alias | - | ||
| English alias | AC-32839 | NCGC00343768-01 | AKOS027422721 | Q27088510 | 71803L5F4S | EX-A426 | RABUSERTIB [WHO-DD] | D10397 | 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-chromen-4-one | BCP9000873 | BCPP000178 | BL166662 | 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosy | ||
| CAS number | 911222-45-2 | molecular formula | C18H22BrN5O3 |
| molecular weight | 436.3 g/mol | Exact mass | - |
| PSA | 97.400 Ų | logp | 1.4 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
